Shenzhen Delica Medical Electronics Co., Ltd. is a national high-tech enterprise focusing on the research, development, and production of craniocerebral disease diagnosis and treatment products in the field of brain science. It has now formed a portfolio of technical solutions covering the diagnosis/monitoring of multiple diseases including stroke, epilepsy, neurocritical care, and syncope.
In 2021, the company was rated as a specialized, refined, distinctive, and innovative "Little Giant" enterprise by the Ministry of Industry and Information Technology; in 2022, it was rated as a Shenzhen manufacturing single champion enterprise (product) by the Shenzhen Municipal Bureau of Industry and Information Technology; in 2023, the "Guangdong Provincial Craniocerebral Ultrasound Engineering Technology Research Center" established by the company passed certification; in 2023, it was rated as a provincial-level manufacturing single champion enterprise (product) by the Guangdong Provincial Department of Industry and Information Technology.
In terms of technology, the company's annual R&D investment in recent years has exceeded 20% of sales revenue. The company's core product, transcranial Doppler, possesses multiple international technologies. It has not only largely replaced imported products in top-tier neurology departments of Class III Grade A hospitals in China, but has also entered developed countries and regions such as Europe and the United States, ranking among the leaders in sales in mainstream international markets. In order to break through the situation where electroencephalograph equipment is monopolized by imports, Delica began concentrating resources on tackling and developing electroencephalograph technology in 2008, launched its first digital multifunctional electroencephalograph in 2012, and has cooperated with many Class III Grade A hospitals, research institutions, and industry experts, continuously investing 10% of revenue in R&D each year to upgrade and optimize it. At present, customers are distributed across more than 900 hospitals nationwide, and its market share ranks among the top three domestic brands in conventional EEG (2023 data from Caizhaowang).
In industry-university-research cooperation, in recent years, the company has jointly undertaken multiple special projects under the National Key R&D Program of the Ministry of Science and Technology with a group of domestic Class III Grade A hospitals and research institutions, and has jointly built "Equipment Innovation and Transformation R&D Bases" with Xuanwu Hospital of Capital Medical University, the First Hospital of Jilin University, Guangdong Provincial Hospital of Chinese Medicine, and others.
In standard formulation, the company is the main drafting unit of the "Pharmaceutical Industry Standard of the People's Republic of China YY/T 0593-2022: Ultrasound Transcranial Doppler System".
In clinical promotion, the company founded a high-quality academic platform in the industry, "Mantianxing Academy", which joins domestic and international experts to conduct nearly 50 online academic livestreams each year, helping to improve the clinical diagnosis and treatment level of primary hospitals.
Delica, intelligently leading the future of craniocerebral technology!
What does Shenzhen Delica Medical Electronics Co., Ltd. require? Who is Delica hiring? Delica recruitment: 计算机/网络/技术类占比最多占36.3%，其次是销售类占34.1%. What education can get in at Delica? 本科占比最多占60.4%，其次是大专占30.8%. High education required at Delica? 硕士占3.3%. Work experience required at Delica? 3-5年占比最多占37.4%，其次是5-10年占25.3%. Where are the job locations at Delica? 深圳占比最多占70.3%，其次是乌鲁木齐占6.6%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
